Efficacy Study to Treat Subjects With Severe Hypertriglyceridemia

Clinical trial NCT01229566 · UNKNOWN

Trial details

NCT number: NCT01229566
Sponsor: Trygg Pharma, Inc.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Severe Hypertriglyceridemia

Start date: 2010-10-01
Primary completion: 2012-07-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.